Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

NERVOUS AND MENTAL DISORDERS OF PARKINSON'S DISEASE

https://doi.org/10.14412/2074-2711-2009-30

Full Text:

Abstract

Parkinson's disease (PD) is a multisystemic neurodegenerative disease involving different mediator systems, which has a wide spectrum of nervous and mental (emotional, cognitive, psychotic, and behavioral) disorders. Nervous and mental diseases are encountered in most patients with PD, at the same time they substantially lower quality of their life. The paper gives the present views of the pathogenesis and clinical presentation of nervous and mental disorders, and approaches to their therapy in PD.

About the Authors

M. R. Nodel'
I.M. Sechenov Moscow Medical Academy
Russian Federation


N. N. Yakhno
I.M. Sechenov Moscow Medical Academy
Russian Federation


References

1. <div><p>Зальялова З.А., Яковлева Л.А., Богданов Э.И. Немоторные проявления болезни Паркинсона. Методическое пособие для постдипломного образования. Казань, 2009.</p><p>Нодель М.Р., Яхно Н.Н. Недвигательные проявления болезни Паркинсона и их влияние на качество жизни. Из кн.: Болезнь Паркинсона и расстройства движений. Руководство для врачей по материалам I Национального конгресса. Москва, 22-23 сентября 2008 г.; с. 92-4.</p><p>Chaudhuri K.R., Healy D.G., Schapira A.H.V. Non-motor symptoms of Parkinsons disease: diagnosis and management. Lancet Neurol 2006; 5:235-45.</p><p>Scaravilli T., Gasparoli E., Rinaldi F et al. Health related quality of life in Parkinsons disease. J Nourol Neurosurg Psychiat 2003; 74(2):163-9.</p><p>Shrag A., Jahanshahi M., Quinn N.P. What contributes to quality life in patients with Parkinsons disease? J Neurol Neurosurg Neuropsych 2000; 69:308-12.</p><p>Mc Kinlay A., Grace R.C., Dalrymple-Alford J.C. et al. A profile of neuropsychiatric problems and their relationship to quality of life for Parkinsons disease. Park and Relat disord 2008; 14:37-42.</p><p>O'Sullivan S.S., Williams D.R., Gallarher D.A. et al. Non motor symptoms as presenting complaints in Parkinsons disease: a clinicopathological study. Mov Disord 2008; 23:101-6.</p><p>Martinez-Martine P., Schapira A.H.V., Stocchi F. et al. Prevalence of non motor symptoms in Parkinsons dis- ease in an international setting: study using non-motor symptoms questionnaire in 545 patients. Mov Dis 2007; 22:1623-9.</p><p>Голубев В.Л. Лечение болезни Паркинсона: ре- шенные и нерешенные вопросы. В кн.: Избран- ные лекции по неврологии. Под ред. В.Л. Голубе- ва. М.: Эйдос Медиа, 2006; с. 395-420.</p><p>Смоленцева И.Г., Левин О.С., Иванов А.Ю. Немоторные флуктуации при болезни Паркинсона. В кн.: Болезнь Паркинсона и расстройства движений. Руководство для врачей по материалам I Национального конгресса. Москва, 22-23 сентября 2008 г.; с. 108-11.</p><p>Chaudhuri K.R., Naidu Y. Early Parkinsons disease and non-motor issues. J Neurology 2008; 255 (Suppl 5):33-8.</p><p>Braak H., Del Tredici K., Rub U. et al. Staging of brain pathology related to sporadic Parkinsons disease. Neurology Aging 2003; 24:197-210.</p><p>Chaudhuri K.R., Schapira A.H.V. Non-motor symptoms of Parkinsons disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009; 8:464-74.</p><p>Merims D., Giladi N. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinsons disease. Park and Relat disord 2008; 14:273-80.</p><p>Robbins T., Evritt B. Neurobehavioral mechanism of reward and motivation. Curr Opin Neurobiol 1996: 6:228-36.</p><p>Politis M., Piccini P., Pavese N. et al. Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinsons disease: an in vivo 11 C-raclopride study. Exp Neurol 2008; 214:112-6.</p><p>Мирецкая А.В., Федорова Н.В., Макаров В.В. Депрессивные расстройства у больных болезнью Паркинсона. В кн.: Болезнь Паркинсона и расстройства движений. Руководство для врачей по материалам 1 Национального конгресса. Москва, 22-23 сентября 2008 г.; с. 97-9.</p><p>Lemke M.R. Depressive symptoms in Parkinsons disease. Eur J Neurol 2008; 15(Suppl. 1):21-5.</p><p>Barone P., Antonini A., Colosimo C. et al. The PRIAMO study: a multicenter assessment of nonmotot symptoms and their impact on quality of life in Parkinson disease. Mov Disord 2009; 24(11):1641-9.</p><p>Shrag A., Jahanshahi M., Quinn N.P. What contributes to depression in Parkinsons disease? Psychol Med 2001; 31:65-73.</p><p>Starkstein S.E., Bolduc P.L., Preziosi T.J. et al. Cognitive impairments in different stages of Parkinsons disease. J Neuropsychiatry 1989; 1:243-8.</p><p>Devos D., Dujardin K., Poirot I. et al. Comparison of desipramine and citalopram treatments with depression in Parkinsons disease: a double-blind placebo- controlled study. Mov Disord 2008; 23:850-7.</p><p>Menza M., Dobkin R.D., Marin H. et al. A con- trolled trial of antidepressants in patients with and depression. Neurology 2009 72:886-92.</p><p>Barone P., Poewe W., Tolosa E. et al. Efficacy of double-blind, placebo-controlled pramipexole against depression in Parkinsons disease. Abstracts of the Movement Disorders Societys Thirteenth International Congress of Parkinson's disease and movement disorders. June 7-11, 2009 (Suppl.1);p. 291.</p><p>Pahwa R., Stacy M.A., Factor S.A. et al. Ropinirole 24-hour prolonged release: a randomized, controlled study in advanced Parkinsons disease. Neurology 2007; 68:1108-16.</p><p>Lydiard R.B. Coexisting depression and anxiety: special diagnostic and treatment issues. J Clin Psychiatry 1991; 52 (Suppl.6):48-54.</p><p>Schiffer R.B., Kurlan R., Rubin A. et al. Evidence of atypical depression in Parkinsons disease. Am J Psychiat 1988; 145:1020-2.</p><p>Menza M., Dobkin R.D. Anxiety. Psychiatric issues in Parkinsons disease. Ed. by Menza M. and Marsh L. London. New York: Taylor &amp; Francis 2006; p. 63-6.</p><p>Lauterbach E.C., Freeman A., Vogel R.L. Correlates of generalized anxiety and panic attacks in dystonia and Parkinsons disease. Cogn Behav Neurol 2003; 16:225-33.</p><p>Pontone G.M., Williams J.R., Anderson K.E. et al. Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinsons disease. Mov Disord 2009; 23:279-84.</p><p>Starkstein S.E., Mayberg H.S., Preziosi T.J. et al. Reliability, validity, and clinical correlates of apathy in Parkinsons disease. J Neuropsychiatry Clin Neurosci 1992; 4(2):134-9.</p><p>Dujardin K., Sockeel P., Devos D. et al. Characteristic of apathy in Parkinsons disease. Mov Disord 2007; 22:778-84.</p><p>Pluck G.C., Brown R.G. Apathy in Parkinsons disease. J Neurol Neurosurg Neuropsych 2002; 73:636-42.</p><p>Pedersen K.F., Larsen J.P., Alves G. et al. Prevalence and clinical correlates of apathy in Parkinsons disease: a community-based study. Park and Relat disord 2009; 15:295-9.</p><p>Campbell J.J., Duffy J.D. Treatment strategies in amotivated patients. Psychiatr Ann 1997; 27:44-9.</p><p>Aarsland D., Mosimann U.P., McKeith I.G. Role of cholinesterase inhibitors in Parkinsons disease and dementia with Lewy bodies. J Geriatr Psychiatry 2000; 15(5):387-92.</p><p>Hilten J.J. van., Weggman M., Velde E.A. Sleep, excessive daytime sleepiness and fatigue in Parkinsons disease. J Neural Transm Park Dis Dement Sect 1993; 5:235-44.</p><p>Hilten J.J. van, Hoogland G., Velde E.A. Diurnal effects of motor activity and fatigue in Parkinsons disease. J Neurol Neurosurg Psychiatr 1993; 56:874-7.</p><p>Schifitto G., Friedman J.H., Oakes D. et al. Fatigue in levodopa-naive subjects with Parkinsons disease. Neurology 2008; 71:481-5.</p><p>Friedman J.H., Friedman H. Fatigue in Parkinsons disease: a nine-year follow-up. Mov Disord 2001; 16:1120-2.</p><p>Alves G., Wentzel-Larsen T., Larsen J.P. Is fatigue an independent and persistent symptom in patients with Parkinsons disease. Neurology 2004;63:1908-11.</p><p>Chaudhuri A., Behan P.O. Fatigue and basal ganglia. J Neurol Sci 2000; 179:34-42.</p><p>Нодель М.Р. Утомляемость при болезни Паркинсона. Журн. неврол. и психиатр. 2009; (9):23-6.</p><p>Williams-Gray C., Foltynie T., Brayne C. et al. Evolution of cognitive dysfunction in an incident Parkinsons disease cohort. Brain 2007; 130:1787-98.</p><p>Захаров В.В., Ярославцева Н.В., Яхно Н.Н. Когнитивные нарушения при болезни Паркинсона. Неврол. журн. 2003; 8(2):11-6.</p><p>Alves G., Forsaa E.B., Pedersen K.F. et. al. Epidemiology of Parkinsons disease. J Neurology 2008; 255 (Suppl 5):18-32.</p><p>Aarsland D., Andersen K., Larsen J.P. et al. Prevalence and characteristics of dementia in Parkinsons disease: an 8-year prospective study. 2003; 60:387-92.</p><p>Степкина Д.А., Захаров В.В., Яхно Н.Н. Когни- тивные нарушения при прогрессировании болез ни Паркинсона. Журн. неврол. и психиатр. 2008; (10):13-9.</p><p>Левин О.С., Смоленцева И.Г., Сэрэнсодном Б. и др. Влияние дофаминергической терапии на нейропсихологические функции у больных болезнью Паркинсона. Неврол. журн. 2004; (3):31-57.</p><p>Нодель М.Р., Яхно Н.Н. Мирапекс (прамипексол) в лечении недвигательных нарушений при болезни Паркинсона. Журн. неврол. и психиатр. 2008; 108(5):32-8.</p><p>De Maindreville A.D., FОnelon G., Mahieux F. Hallucinations in Parkinson's disease: a follow-up study. Mov Disord 2005; 20(2):212-7.</p><p>Diederich N.J., Goetz C.G., Stebbins G.T. Repeated visual hallucinations in Parkinsons disease as disturbed external/internal perceprion: focused review and a new intergrative model. Mov Disord 2005; 20:7130-40.</p><p>Arnulf I., Bonnet A.M., Damier P. et al. Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis. Neurology 2000; 55(2):281-8.</p><p>Comella C.L., Tanner C.M., Ristanovic R.K. Polysomnographic sleep measures in Parkinson's dis- ease patients with treatment-induced hallucinations. Ann Neurol 1993; 34(5):710-4.</p><p>Кулуа Т. Ночные симптомы болезни Паркинсона. В кн.: Болезнь Паркинсона и расстройства движений. Руководство для врачей по материалам I Национального конгресса. Москва, 22-23 сентября 2008 г.; с. 100-3.</p><p>Нодель М.Р. Нарушения сна при болезни Паркинсона. В кн.: Болезнь Паркинсона и расстройства движений. Руководство для врачей по материалам I Национального конгресса. Москва, 22- 23 сентября 2008 г.; с. 277.</p><p>Scaglione C., Vignatelli L., Plazzi G. et al. REM sleep behaviour disorder in Parkinsons disease: a questionnaire-based study. Neurol Sci 2005; 25:316-21.</p><p>Brodsky M.A., Godbold J., Roth T. et al. Sleepiness in Parkinson's disease: a controlled study. Mov Disord 2003; 18(6):668-72.</p><p>Monaca C., A. Duhamel A., Jacquesson J.M. et al. Vigilance troubles in Parkinson's disease: A subjective- and objective polysomnographic study. Sleep Medicine 2006; 7:448-53.</p><p>Gjerstad M.D., Aarsland D., Larsen J.P. Development of daytime somnolence over time in Parkinson's disease Neurology 2002; 58(10):1544-6.</p><p>Shpirer I., Miniovitz A., Klein C. et. al. Excessive Daytime Sleepiness in Patients With Parkinson's disease: A Polysomnography Study. Mov Disord 2006; 21(9):1432-8.</p><p>Rye D.B., Bliwise D.L., Dihenia B. et al. FAST TRACK: daytime sleepiness in Parkinson's disease. J Sleep Res 2000; 9(1):63-9.</p><p>Katzenschalger R., Evans A. Impulse dyscontrol and dopamine dysregulation syndrome. In Non-motor symptoms of Parkinsons disease. Ed. by K.R. Chaudhuri et al. New York 2009. Oxford University Press Inc.</p><p>Ondo W., Lai D. Predictors of impulsivity and reward seeking behavior with dopamine agonists. Park and Relat disord 2008; 14:28-32.</p><p>Silveria-Moriyama L., Evans A.H., Katzenschlager R. Punding and dyskinesias. Mov Disord 2006; 21(9):2214-17.</p><p>Kurlan К. Disabling repetitive behaviors in Parkinsons disease. Mov Disord 2004; 19:433-69.</p></div><br />


For citation:


Nodel' M.R., Yakhno N.N. NERVOUS AND MENTAL DISORDERS OF PARKINSON'S DISEASE. Neurology, Neuropsychiatry, Psychosomatics. 2009;1(2):3-8. (In Russ.) https://doi.org/10.14412/2074-2711-2009-30

Views: 1218


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)